Long-term follow-up for multidrug-resistant tuberculosis
- PMID: 16704823
- PMCID: PMC3294679
- DOI: 10.3201/eid1204.041256
Long-term follow-up for multidrug-resistant tuberculosis
Abstract
Patients treated in Peru for multidrug-resistant tuberculosis (MDR-TB) were followed-up for a median of 67 months. Among 86 patients considered cured after completion of treatment, 97% remain healthy; 1 patient relapsed. Employment increased from 34% before treatment to 71%. We observed favorable long-term outcomes among MDR-TB patients.
References
-
- Leimane V, Riekstina V, Holtz T, Zarovska E, Skripconoka V, Thorpe L, et al. Clinical outcome of individualized treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study. Lancet. 2005;365:318–26. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical